

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | maturation of SSU-rRNA (GO:0030490) | 7.52596541 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 6.40798494 |
| 3 | COPI coating of Golgi vesicle (GO:0048205) | 6.40798494 |
| 4 | ribosomal small subunit biogenesis (GO:0042274) | 5.86735286 |
| 5 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 5.17732121 |
| 6 | translational initiation (GO:0006413) | 4.92859649 |
| 7 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.89504315 |
| 8 | DNA unwinding involved in DNA replication (GO:0006268) | 4.70286910 |
| 9 | cellular protein complex disassembly (GO:0043624) | 4.69804470 |
| 10 | ribosomal large subunit biogenesis (GO:0042273) | 4.65082328 |
| 11 | protein retention in ER lumen (GO:0006621) | 4.62944800 |
| 12 | viral life cycle (GO:0019058) | 4.62762826 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.40631948 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.40631948 |
| 15 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 4.39253510 |
| 16 | protein complex disassembly (GO:0043241) | 4.38036345 |
| 17 | transcription from RNA polymerase I promoter (GO:0006360) | 4.33175576 |
| 18 | DNA topological change (GO:0006265) | 4.14556935 |
| 19 | macromolecular complex disassembly (GO:0032984) | 4.12018109 |
| 20 | actin-myosin filament sliding (GO:0033275) | 4.10051778 |
| 21 | muscle filament sliding (GO:0030049) | 4.10051778 |
| 22 | negative regulation of RNA splicing (GO:0033119) | 4.00335590 |
| 23 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.93034886 |
| 24 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.87819837 |
| 25 | DNA replication checkpoint (GO:0000076) | 3.84573697 |
| 26 | negative regulation of mRNA processing (GO:0050686) | 3.83875491 |
| 27 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.81189597 |
| 28 | translation (GO:0006412) | 3.80246715 |
| 29 | mRNA splice site selection (GO:0006376) | 3.78051298 |
| 30 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.77856186 |
| 31 | purine nucleotide salvage (GO:0032261) | 3.77028981 |
| 32 | viral mRNA export from host cell nucleus (GO:0046784) | 3.76932440 |
| 33 | positive regulation of nuclease activity (GO:0032075) | 3.74654957 |
| 34 | regulation of translational fidelity (GO:0006450) | 3.69659203 |
| 35 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.69348503 |
| 36 | DNA strand elongation (GO:0022616) | 3.63949736 |
| 37 | mRNA catabolic process (GO:0006402) | 3.61523201 |
| 38 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.60481896 |
| 39 | rRNA processing (GO:0006364) | 3.56206315 |
| 40 | plasma membrane repair (GO:0001778) | 3.55662729 |
| 41 | mRNA splicing, via spliceosome (GO:0000398) | 3.53269914 |
| 42 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 3.53269914 |
| 43 | sarcomere organization (GO:0045214) | 3.50445221 |
| 44 | nucleobase biosynthetic process (GO:0046112) | 3.49080896 |
| 45 | RNA splicing, via transesterification reactions (GO:0000375) | 3.48964739 |
| 46 | oxaloacetate metabolic process (GO:0006107) | 3.48071575 |
| 47 | regulation of nuclease activity (GO:0032069) | 3.47738369 |
| 48 | protein targeting to membrane (GO:0006612) | 3.45437888 |
| 49 | purine nucleobase biosynthetic process (GO:0009113) | 3.44724746 |
| 50 | ribonucleoprotein complex assembly (GO:0022618) | 3.41234721 |
| 51 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.41020728 |
| 52 | rRNA metabolic process (GO:0016072) | 3.40508569 |
| 53 | protein maturation by protein folding (GO:0022417) | 3.40260054 |
| 54 | RNA catabolic process (GO:0006401) | 3.40258269 |
| 55 | termination of RNA polymerase II transcription (GO:0006369) | 3.38576372 |
| 56 | 4-hydroxyproline metabolic process (GO:0019471) | 3.38242767 |
| 57 | mitotic sister chromatid segregation (GO:0000070) | 3.35263898 |
| 58 | tricarboxylic acid cycle (GO:0006099) | 3.32636693 |
| 59 | activated T cell proliferation (GO:0050798) | 3.31078440 |
| 60 | tricarboxylic acid metabolic process (GO:0072350) | 3.30800181 |
| 61 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.28092963 |
| 62 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.27185902 |
| 63 | negative regulation of mRNA metabolic process (GO:1903312) | 3.26965382 |
| 64 | sister chromatid segregation (GO:0000819) | 3.26572526 |
| 65 | ncRNA 3-end processing (GO:0043628) | 3.25258477 |
| 66 | regulation of mitochondrial translation (GO:0070129) | 3.24415067 |
| 67 | cellular component biogenesis (GO:0044085) | 3.23284717 |
| 68 | ribonucleoprotein complex subunit organization (GO:0071826) | 3.21057434 |
| 69 | COPII vesicle coating (GO:0048208) | 3.20602688 |
| 70 | ribosomal small subunit assembly (GO:0000028) | 3.16686972 |
| 71 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.15969830 |
| 72 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.15847946 |
| 73 | cellular response to unfolded protein (GO:0034620) | 3.15236259 |
| 74 | nuclear pore complex assembly (GO:0051292) | 3.13901526 |
| 75 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.13745152 |
| 76 | ATP synthesis coupled proton transport (GO:0015986) | 3.13745152 |
| 77 | termination of RNA polymerase I transcription (GO:0006363) | 3.12429174 |
| 78 | heterochromatin organization (GO:0070828) | 3.10354605 |
| 79 | ribosome biogenesis (GO:0042254) | 3.08054822 |
| 80 | pentose-phosphate shunt (GO:0006098) | 3.07125306 |
| 81 | valine metabolic process (GO:0006573) | 3.06978026 |
| 82 | DNA-templated transcription, termination (GO:0006353) | 3.05923061 |
| 83 | peptidyl-proline hydroxylation (GO:0019511) | 3.05404021 |
| 84 | alternative mRNA splicing, via spliceosome (GO:0000380) | 3.05308852 |
| 85 | cellular response to topologically incorrect protein (GO:0035967) | 3.05153009 |
| 86 | RNA export from nucleus (GO:0006405) | 3.04742359 |
| 87 | DNA damage response, detection of DNA damage (GO:0042769) | 3.03315018 |
| 88 | actin-mediated cell contraction (GO:0070252) | 3.02641786 |
| 89 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.00553978 |
| 90 | protein hydroxylation (GO:0018126) | 2.99743414 |
| 91 | negative regulation of cell size (GO:0045792) | 2.99576156 |
| 92 | DNA replication initiation (GO:0006270) | 2.99364879 |
| 93 | ER-nucleus signaling pathway (GO:0006984) | 2.97081144 |
| 94 | mRNA export from nucleus (GO:0006406) | 2.96318914 |
| 95 | 2-oxoglutarate metabolic process (GO:0006103) | 2.95832731 |
| 96 | regulation of translational elongation (GO:0006448) | 2.91752311 |
| 97 | peptidyl-histidine modification (GO:0018202) | 2.91570598 |
| 98 | mRNA polyadenylation (GO:0006378) | 2.90568984 |
| 99 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 2.90335424 |
| 100 | barbed-end actin filament capping (GO:0051016) | 2.90276051 |
| 101 | IMP metabolic process (GO:0046040) | 2.90244729 |
| 102 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.88736783 |
| 103 | mitotic chromosome condensation (GO:0007076) | 2.88493487 |
| 104 | spliceosomal snRNP assembly (GO:0000387) | 2.88276985 |
| 105 | NADH metabolic process (GO:0006734) | 2.87850939 |
| 106 | regulation of histone H3-K4 methylation (GO:0051569) | 2.87114047 |
| 107 | galactose catabolic process (GO:0019388) | 2.86959249 |
| 108 | regulation of skeletal muscle contraction (GO:0014819) | 2.86628226 |
| 109 | histone H2B ubiquitination (GO:0033523) | 2.85402576 |
| 110 | chromatin remodeling at centromere (GO:0031055) | 2.85280213 |
| 111 | purine-containing compound salvage (GO:0043101) | 2.84762222 |
| 112 | maternal placenta development (GO:0001893) | 2.83706788 |
| 113 | regulation of DNA damage checkpoint (GO:2000001) | 2.83634888 |
| 114 | RNA splicing (GO:0008380) | 2.81826090 |
| 115 | IMP biosynthetic process (GO:0006188) | 2.81085752 |
| 116 | protein localization to kinetochore (GO:0034501) | 2.80162225 |
| 117 | mitotic recombination (GO:0006312) | 2.77070764 |
| 118 | ncRNA processing (GO:0034470) | 2.76504793 |
| 119 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.76106193 |
| 120 | nuclear pore organization (GO:0006999) | 2.73148859 |
| 121 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 2.72968846 |
| 122 | mRNA 3-end processing (GO:0031124) | 2.72700927 |
| 123 | RNA polyadenylation (GO:0043631) | 2.71359832 |
| 124 | sequestering of metal ion (GO:0051238) | 2.71128293 |
| 125 | telomere maintenance via recombination (GO:0000722) | 2.70299048 |
| 126 | spliceosomal complex assembly (GO:0000245) | 2.68990454 |
| 127 | mitotic nuclear envelope disassembly (GO:0007077) | 2.68848408 |
| 128 | DNA duplex unwinding (GO:0032508) | 2.68520172 |
| 129 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.68364170 |
| 130 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.65382615 |
| 131 | RNA 3-end processing (GO:0031123) | 2.64761371 |
| 132 | mitochondrial calcium ion transport (GO:0006851) | 2.61666122 |
| 133 | histone deubiquitination (GO:0016578) | 2.61556860 |
| 134 | rRNA modification (GO:0000154) | 2.61324092 |
| 135 | kinetochore organization (GO:0051383) | 2.61266874 |
| 136 | lysine catabolic process (GO:0006554) | 2.59310275 |
| 137 | lysine metabolic process (GO:0006553) | 2.59310275 |
| 138 | protein targeting to ER (GO:0045047) | 2.57828353 |
| 139 | NADPH regeneration (GO:0006740) | 2.57318464 |
| 140 | activation of MAPKKK activity (GO:0000185) | 2.56653558 |
| 141 | response to unfolded protein (GO:0006986) | 2.55975726 |
| 142 | signal peptide processing (GO:0006465) | 2.55259179 |
| 143 | cotranslational protein targeting to membrane (GO:0006613) | 2.52227660 |
| 144 | formation of translation preinitiation complex (GO:0001731) | 2.51243142 |
| 145 | nucleotide salvage (GO:0043173) | 2.49752634 |
| 146 | response to topologically incorrect protein (GO:0035966) | 2.48693910 |
| 147 | translational elongation (GO:0006414) | 2.46426772 |
| 148 | apoptotic cell clearance (GO:0043277) | 2.46177206 |
| 149 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.45734448 |
| 150 | negative regulation of fatty acid transport (GO:2000192) | 2.45139330 |
| 151 | vesicle coating (GO:0006901) | 2.44828574 |
| 152 | response to endoplasmic reticulum stress (GO:0034976) | 2.43402030 |
| 153 | protein localization to endoplasmic reticulum (GO:0070972) | 2.43216283 |
| 154 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.41403427 |
| 155 | skin morphogenesis (GO:0043589) | 2.41293529 |
| 156 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.40111507 |
| 157 | viral transcription (GO:0019083) | 2.38869620 |
| 158 | T cell apoptotic process (GO:0070231) | 2.37055150 |
| 159 | regulation of fatty acid oxidation (GO:0046320) | 2.35689010 |
| 160 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.33373166 |
| 161 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.33346241 |
| 162 | heme biosynthetic process (GO:0006783) | 2.31206641 |
| 163 | AMP metabolic process (GO:0046033) | 2.28107235 |
| 164 | translational termination (GO:0006415) | 2.27604277 |
| 165 | ethanol oxidation (GO:0006069) | 2.26788246 |
| 166 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176) | 2.24570344 |
| 167 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.23905430 |
| 168 | positive regulation of lamellipodium assembly (GO:0010592) | 2.23262817 |
| 169 | proline biosynthetic process (GO:0006561) | 2.22806827 |
| 170 | * ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.22696523 |
| 171 | actin filament-based movement (GO:0030048) | 2.20507974 |
| 172 | platelet aggregation (GO:0070527) | 2.18496809 |
| 173 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.18192306 |
| 174 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.17580583 |
| 175 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.15059554 |
| 176 | low-density lipoprotein particle clearance (GO:0034383) | 2.14691570 |
| 177 | primary alcohol catabolic process (GO:0034310) | 2.14491421 |
| 178 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.14440231 |
| 179 | negative regulation of fibrinolysis (GO:0051918) | 2.13929024 |
| 180 | DNA deamination (GO:0045006) | 2.13840981 |
| 181 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.13107734 |
| 182 | skeletal muscle contraction (GO:0003009) | 2.12886316 |
| 183 | oxidative phosphorylation (GO:0006119) | 2.10225496 |
| 184 | cellular response to arsenic-containing substance (GO:0071243) | 2.09644047 |
| 185 | glucose catabolic process (GO:0006007) | 2.08835428 |
| 186 | regulation of translational termination (GO:0006449) | 2.08426724 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.75239779 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.57184073 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.43522312 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.90645963 |
| 5 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.83252468 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.70676564 |
| 7 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.52446169 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.50355866 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.49060074 |
| 10 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.47810182 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.39797048 |
| 12 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.38192593 |
| 13 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.37152752 |
| 14 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.34556706 |
| 15 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.28834321 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.28230705 |
| 17 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.25641179 |
| 18 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.20428144 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.00018992 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.95639664 |
| 21 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88318488 |
| 22 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.86082875 |
| 23 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.86031324 |
| 24 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.86010521 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.85288272 |
| 26 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.84958468 |
| 27 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.83763347 |
| 28 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82197553 |
| 29 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.80297711 |
| 30 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.77875423 |
| 31 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.77175778 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.75856991 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.75816967 |
| 34 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.74331335 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74236095 |
| 36 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.72530261 |
| 37 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.68914931 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.67701575 |
| 39 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.66959007 |
| 40 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.65911608 |
| 41 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.63657202 |
| 42 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.63537037 |
| 43 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.61939661 |
| 44 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.61853519 |
| 45 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.61754330 |
| 46 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60584935 |
| 47 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.59453391 |
| 48 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.53380734 |
| 49 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.52396644 |
| 50 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.52233137 |
| 51 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.51522655 |
| 52 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.49759221 |
| 53 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.44740171 |
| 54 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43982493 |
| 55 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.43185641 |
| 56 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.42362189 |
| 57 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.41856213 |
| 58 | MAF_26560356_Chip-Seq_TH1_Human | 1.41480397 |
| 59 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.41478560 |
| 60 | ATF3_27146783_Chip-Seq_COLON_Human | 1.40865380 |
| 61 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.40315329 |
| 62 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.39744874 |
| 63 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.39452955 |
| 64 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.39324483 |
| 65 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.37530755 |
| 66 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.36022784 |
| 67 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.35374777 |
| 68 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.34519901 |
| 69 | UTX_26944678_Chip-Seq_JUKART_Human | 1.34154706 |
| 70 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.33681682 |
| 71 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.32392930 |
| 72 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.32304800 |
| 73 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.31918665 |
| 74 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30129399 |
| 75 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.29834182 |
| 76 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.29434404 |
| 77 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29095555 |
| 78 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.28820480 |
| 79 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.28783245 |
| 80 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.28609652 |
| 81 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.28494726 |
| 82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27931228 |
| 83 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.27411265 |
| 84 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.27334459 |
| 85 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.26782642 |
| 86 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.26128293 |
| 87 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.25220146 |
| 88 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.24296150 |
| 89 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.24291355 |
| 90 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.23351803 |
| 91 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.21968408 |
| 92 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.21852866 |
| 93 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21461214 |
| 94 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.20981230 |
| 95 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.20883418 |
| 96 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20728990 |
| 97 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.20677867 |
| 98 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.20646555 |
| 99 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.20012924 |
| 100 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.19948792 |
| 101 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.19762592 |
| 102 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18846362 |
| 103 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.17392303 |
| 104 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.17113841 |
| 105 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.16954222 |
| 106 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.16527929 |
| 107 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.16515141 |
| 108 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16325792 |
| 109 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.14714968 |
| 110 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.14322760 |
| 111 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12761210 |
| 112 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.12428245 |
| 113 | GATA1_22025678_ChIP-Seq_K562_Human | 1.12081685 |
| 114 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.10631241 |
| 115 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.10107088 |
| 116 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09927342 |
| 117 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.08335953 |
| 118 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07536846 |
| 119 | MYB_26560356_Chip-Seq_TH2_Human | 1.07200468 |
| 120 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.07062014 |
| 121 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06946068 |
| 122 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.06275427 |
| 123 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04685329 |
| 124 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04535214 |
| 125 | MAF_26560356_Chip-Seq_TH2_Human | 1.03971920 |
| 126 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.03760325 |
| 127 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.02621386 |
| 128 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.02396735 |
| 129 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01564502 |
| 130 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.01077324 |
| 131 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.01024090 |
| 132 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.00797220 |
| 133 | MYB_26560356_Chip-Seq_TH1_Human | 1.00159979 |
| 134 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.99871916 |
| 135 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.98431652 |
| 136 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.98271868 |
| 137 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.98125886 |
| 138 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97961711 |
| 139 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.97715068 |
| 140 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.97229739 |
| 141 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.93644591 |
| 142 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.92414186 |
| 143 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.90795006 |
| 144 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.90268789 |
| 145 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.84419537 |
| 146 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.83336344 |
| 147 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.83027034 |
| 148 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.79719328 |
| 149 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.79013218 |
| 150 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.73241492 |
| 151 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71317809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 4.04153224 |
| 2 | MP0010094_abnormal_chromosome_stability | 3.85440165 |
| 3 | MP0003111_abnormal_nucleus_morphology | 3.63666930 |
| 4 | MP0002396_abnormal_hematopoietic_system | 2.99697858 |
| 5 | MP0000372_irregular_coat_pigmentation | 2.86681606 |
| 6 | MP0008058_abnormal_DNA_repair | 2.75592704 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.72882286 |
| 8 | MP0002837_dystrophic_cardiac_calcinosis | 2.69699128 |
| 9 | MP0000749_muscle_degeneration | 2.60296139 |
| 10 | MP0004957_abnormal_blastocyst_morpholog | 2.58045662 |
| 11 | MP0005075_abnormal_melanosome_morpholog | 2.56279088 |
| 12 | MP0008007_abnormal_cellular_replicative | 2.51732820 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.47115158 |
| 14 | MP0003077_abnormal_cell_cycle | 2.46899691 |
| 15 | MP0005408_hypopigmentation | 2.46877699 |
| 16 | MP0006035_abnormal_mitochondrial_morpho | 2.43715518 |
| 17 | MP0008995_early_reproductive_senescence | 2.28500661 |
| 18 | MP0006292_abnormal_olfactory_placode | 2.24379241 |
| 19 | MP0006054_spinal_hemorrhage | 2.22670380 |
| 20 | MP0000751_myopathy | 2.21515755 |
| 21 | MP0000750_abnormal_muscle_regeneration | 2.19380474 |
| 22 | MP0008057_abnormal_DNA_replication | 2.18911588 |
| 23 | MP0003646_muscle_fatigue | 2.16634703 |
| 24 | MP0003786_premature_aging | 2.07409662 |
| 25 | MP0000013_abnormal_adipose_tissue | 1.94072300 |
| 26 | MP0003567_abnormal_fetal_cardiomyocyte | 1.92023061 |
| 27 | MP0008932_abnormal_embryonic_tissue | 1.91208875 |
| 28 | MP0004084_abnormal_cardiac_muscle | 1.91040954 |
| 29 | MP0003566_abnormal_cell_adhesion | 1.86419121 |
| 30 | MP0000747_muscle_weakness | 1.86175618 |
| 31 | MP0003136_yellow_coat_color | 1.78848125 |
| 32 | MP0001529_abnormal_vocalization | 1.70718929 |
| 33 | MP0009840_abnormal_foam_cell | 1.70590276 |
| 34 | MP0004087_abnormal_muscle_fiber | 1.70305385 |
| 35 | MP0002269_muscular_atrophy | 1.69341430 |
| 36 | MP0005058_abnormal_lysosome_morphology | 1.65352658 |
| 37 | MP0004036_abnormal_muscle_relaxation | 1.61939431 |
| 38 | MP0010368_abnormal_lymphatic_system | 1.61710247 |
| 39 | MP0004381_abnormal_hair_follicle | 1.61537573 |
| 40 | MP0003279_aneurysm | 1.61230978 |
| 41 | MP0005171_absent_coat_pigmentation | 1.58556835 |
| 42 | MP0001730_embryonic_growth_arrest | 1.57854018 |
| 43 | MP0003436_decreased_susceptibility_to | 1.57612792 |
| 44 | MP0005330_cardiomyopathy | 1.57152576 |
| 45 | MP0000759_abnormal_skeletal_muscle | 1.53731379 |
| 46 | MP0000350_abnormal_cell_proliferation | 1.52237959 |
| 47 | MP0002877_abnormal_melanocyte_morpholog | 1.51310141 |
| 48 | MP0000703_abnormal_thymus_morphology | 1.51040311 |
| 49 | MP0003806_abnormal_nucleotide_metabolis | 1.50593618 |
| 50 | MP0000858_altered_metastatic_potential | 1.50342195 |
| 51 | MP0004130_abnormal_muscle_cell | 1.49039768 |
| 52 | MP0010352_gastrointestinal_tract_polyps | 1.48076905 |
| 53 | MP0005275_abnormal_skin_tensile | 1.47549367 |
| 54 | MP0003011_delayed_dark_adaptation | 1.46158022 |
| 55 | MP0010307_abnormal_tumor_latency | 1.46149553 |
| 56 | MP0006036_abnormal_mitochondrial_physio | 1.45283915 |
| 57 | MP0002106_abnormal_muscle_physiology | 1.44937513 |
| 58 | MP0002095_abnormal_skin_pigmentation | 1.44496190 |
| 59 | MP0000343_altered_response_to | 1.41553680 |
| 60 | MP0005023_abnormal_wound_healing | 1.41336852 |
| 61 | MP0005083_abnormal_biliary_tract | 1.40371992 |
| 62 | MP0004233_abnormal_muscle_weight | 1.40251850 |
| 63 | MP0000685_abnormal_immune_system | 1.38549086 |
| 64 | MP0005365_abnormal_bile_salt | 1.35563809 |
| 65 | MP0005220_abnormal_exocrine_pancreas | 1.33361805 |
| 66 | MP0005174_abnormal_tail_pigmentation | 1.28594723 |
| 67 | MP0004808_abnormal_hematopoietic_stem | 1.26576445 |
| 68 | MP0003221_abnormal_cardiomyocyte_apopto | 1.25556391 |
| 69 | MP0000371_diluted_coat_color | 1.24343968 |
| 70 | MP0010630_abnormal_cardiac_muscle | 1.23467841 |
| 71 | MP0003656_abnormal_erythrocyte_physiolo | 1.22748117 |
| 72 | MP0000313_abnormal_cell_death | 1.21761498 |
| 73 | MP0003300_gastrointestinal_ulcer | 1.20966082 |
| 74 | MP0009333_abnormal_splenocyte_physiolog | 1.17154082 |
| 75 | MP0001697_abnormal_embryo_size | 1.17150356 |
| 76 | MP0002938_white_spotting | 1.16852983 |
| 77 | MP0001672_abnormal_embryogenesis/_devel | 1.16483645 |
| 78 | MP0005380_embryogenesis_phenotype | 1.16483645 |
| 79 | MP0002080_prenatal_lethality | 1.16156011 |
| 80 | MP0000733_abnormal_muscle_development | 1.15329555 |
| 81 | MP0001545_abnormal_hematopoietic_system | 1.14572106 |
| 82 | MP0005397_hematopoietic_system_phenotyp | 1.14572106 |
| 83 | MP0003984_embryonic_growth_retardation | 1.13291056 |
| 84 | MP0004145_abnormal_muscle_electrophysio | 1.12807040 |
| 85 | MP0005319_abnormal_enzyme/_coenzyme | 1.11895217 |
| 86 | MP0001835_abnormal_antigen_presentation | 1.11441963 |
| 87 | MP0002088_abnormal_embryonic_growth/wei | 1.10716272 |
| 88 | MP0005369_muscle_phenotype | 1.10222703 |
| 89 | MP0003191_abnormal_cellular_cholesterol | 1.09794076 |
| 90 | MP0009785_altered_susceptibility_to | 1.09280578 |
| 91 | MP0004947_skin_inflammation | 1.08769622 |
| 92 | MP0001533_abnormal_skeleton_physiology | 1.07492592 |
| 93 | MP0001544_abnormal_cardiovascular_syste | 1.07232894 |
| 94 | MP0005385_cardiovascular_system_phenoty | 1.07232894 |
| 95 | MP0003303_peritoneal_inflammation | 1.07192236 |
| 96 | MP0005464_abnormal_platelet_physiology | 1.07080660 |
| 97 | MP0002933_joint_inflammation | 1.05469718 |
| 98 | MP0004147_increased_porphyrin_level | 1.05245890 |
| 99 | MP0001293_anophthalmia | 1.05200420 |
| 100 | MP0003186_abnormal_redox_activity | 1.03690936 |
| 101 | MP0004185_abnormal_adipocyte_glucose | 1.03599687 |
| 102 | MP0003172_abnormal_lysosome_physiology | 1.02988971 |
| 103 | MP0008260_abnormal_autophagy | 1.02004805 |
| 104 | MP0002210_abnormal_sex_determination | 1.01477042 |
| 105 | MP0003937_abnormal_limbs/digits/tail_de | 1.00096653 |
| 106 | MP0002166_altered_tumor_susceptibility | 1.00088530 |
| 107 | MP0009672_abnormal_birth_weight | 0.99723016 |
| 108 | MP0005620_abnormal_muscle_contractility | 0.99325866 |
| 109 | MP0000609_abnormal_liver_physiology | 0.99295100 |
| 110 | MP0001661_extended_life_span | 0.98480619 |
| 111 | MP0002075_abnormal_coat/hair_pigmentati | 0.97425592 |
| 112 | MP0004510_myositis | 0.97036993 |
| 113 | MP0000598_abnormal_liver_morphology | 0.96657215 |
| 114 | MP0003693_abnormal_embryo_hatching | 0.96118351 |
| 115 | MP0002139_abnormal_hepatobiliary_system | 0.95042515 |
| 116 | MP0002019_abnormal_tumor_incidence | 0.94973483 |
| 117 | MP0001186_pigmentation_phenotype | 0.94908852 |
| 118 | MP0000358_abnormal_cell_content/ | 0.94853334 |
| 119 | MP0003763_abnormal_thymus_physiology | 0.94505182 |
| 120 | MP0003724_increased_susceptibility_to | 0.94336249 |
| 121 | MP0001873_stomach_inflammation | 0.94180214 |
| 122 | MP0002909_abnormal_adrenal_gland | 0.93184888 |
| 123 | MP0005025_abnormal_response_to | 0.92673126 |
| 124 | MP0000462_abnormal_digestive_system | 0.92566473 |
| 125 | MP0001727_abnormal_embryo_implantation | 0.91514589 |
| 126 | MP0002722_abnormal_immune_system | 0.91029462 |
| 127 | MP0002693_abnormal_pancreas_physiology | 0.90835146 |
| 128 | MP0003938_abnormal_ear_development | 0.90333130 |
| 129 | MP0003283_abnormal_digestive_organ | 0.90307886 |
| 130 | MP0002085_abnormal_embryonic_tissue | 0.90222964 |
| 131 | MP0009697_abnormal_copulation | 0.90187188 |
| 132 | MP0009643_abnormal_urine_homeostasis | 0.89632474 |
| 133 | MP0001958_emphysema | 0.88788027 |
| 134 | MP0008961_abnormal_basal_metabolism | 0.87983518 |
| 135 | MP0001944_abnormal_pancreas_morphology | 0.87380561 |
| 136 | MP0003315_abnormal_perineum_morphology | 0.87362510 |
| 137 | MP0005670_abnormal_white_adipose | 0.86816570 |
| 138 | MP0002972_abnormal_cardiac_muscle | 0.86793618 |
| 139 | MP0001853_heart_inflammation | 0.86786285 |
| 140 | MP0002084_abnormal_developmental_patter | 0.86658010 |
| 141 | MP0001845_abnormal_inflammatory_respons | 0.86517581 |
| 142 | MP0000428_abnormal_craniofacial_morphol | 0.85841316 |
| 143 | MP0002419_abnormal_innate_immunity | 0.85545251 |
| 144 | MP0000003_abnormal_adipose_tissue | 0.85441695 |
| 145 | MP0000015_abnormal_ear_pigmentation | 0.85288429 |
| 146 | MP0002108_abnormal_muscle_morphology | 0.85163721 |
| 147 | MP0008469_abnormal_protein_level | 0.84580383 |
| 148 | MP0005076_abnormal_cell_differentiation | 0.83918582 |
| 149 | MP0003828_pulmonary_edema | 0.82799793 |
| 150 | MP0005375_adipose_tissue_phenotype | 0.82092559 |
| 151 | MP0002398_abnormal_bone_marrow | 0.81940417 |
| 152 | MP0001145_abnormal_male_reproductive | 0.81319052 |
| 153 | MP0009278_abnormal_bone_marrow | 0.80110826 |
| 154 | MP0002128_abnormal_blood_circulation | 0.79887799 |
| 155 | MP0000689_abnormal_spleen_morphology | 0.79834546 |
| 156 | MP0002234_abnormal_pharynx_morphology | 0.79610271 |
| 157 | MP0004215_abnormal_myocardial_fiber | 0.79427721 |
| 158 | MP0000767_abnormal_smooth_muscle | 0.79004569 |
| 159 | MP0001879_abnormal_lymphatic_vessel | 0.78918027 |
| 160 | MP0000249_abnormal_blood_vessel | 0.78768568 |
| 161 | MP0002078_abnormal_glucose_homeostasis | 0.78669272 |
| 162 | MP0001243_abnormal_dermal_layer | 0.78508755 |
| 163 | MP0005000_abnormal_immune_tolerance | 0.78262499 |
| 164 | MP0004197_abnormal_fetal_growth/weight/ | 0.77331489 |
| 165 | MP0001324_abnormal_eye_pigmentation | 0.74291265 |
| 166 | MP0002429_abnormal_blood_cell | 0.73335099 |
| 167 | MP0002009_preneoplasia | 0.72989129 |
| 168 | MP0003943_abnormal_hepatobiliary_system | 0.70410311 |
| 169 | MP0001851_eye_inflammation | 0.69082806 |
| 170 | MP0000049_abnormal_middle_ear | 0.68824239 |
| 171 | MP0004142_abnormal_muscle_tone | 0.68128351 |
| 172 | MP0002086_abnormal_extraembryonic_tissu | 0.66147541 |
| 173 | MP0000653_abnormal_sex_gland | 0.65409827 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Reticulocytopenia (HP:0001896) | 5.19075841 |
| 2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.81837922 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 4.78251646 |
| 4 | Muscle fiber inclusion bodies (HP:0100299) | 4.38842562 |
| 5 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.30183380 |
| 6 | Microvesicular hepatic steatosis (HP:0001414) | 4.15984430 |
| 7 | Nemaline bodies (HP:0003798) | 3.98901361 |
| 8 | Type 1 muscle fiber predominance (HP:0003803) | 3.96733982 |
| 9 | Macrocytic anemia (HP:0001972) | 3.87610195 |
| 10 | Protrusio acetabuli (HP:0003179) | 3.64785643 |
| 11 | Myoglobinuria (HP:0002913) | 3.48617337 |
| 12 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.45434834 |
| 13 | Distal arthrogryposis (HP:0005684) | 3.44309766 |
| 14 | Pallor (HP:0000980) | 3.41842714 |
| 15 | 11 pairs of ribs (HP:0000878) | 3.29703302 |
| 16 | Asymmetric septal hypertrophy (HP:0001670) | 3.28537063 |
| 17 | Increased connective tissue (HP:0009025) | 3.25644067 |
| 18 | Myopathic facies (HP:0002058) | 3.17289559 |
| 19 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.17273496 |
| 20 | Exercise-induced muscle cramps (HP:0003710) | 3.16657096 |
| 21 | Mesomelia (HP:0003027) | 3.13764452 |
| 22 | Ulnar deviation of the wrist (HP:0003049) | 3.12930737 |
| 23 | Exercise-induced myalgia (HP:0003738) | 3.11566544 |
| 24 | Hypoglycemic coma (HP:0001325) | 3.10414107 |
| 25 | Chromsome breakage (HP:0040012) | 3.04008973 |
| 26 | Rhabdomyolysis (HP:0003201) | 3.02802083 |
| 27 | Muscle fiber splitting (HP:0003555) | 2.99308732 |
| 28 | Broad distal phalanx of finger (HP:0009836) | 2.96464801 |
| 29 | Abnormality of reticulocytes (HP:0004312) | 2.91344386 |
| 30 | Nasal speech (HP:0001611) | 2.91277260 |
| 31 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.91095312 |
| 32 | Sparse scalp hair (HP:0002209) | 2.87717763 |
| 33 | Difficulty climbing stairs (HP:0003551) | 2.84537074 |
| 34 | Acute necrotizing encephalopathy (HP:0006965) | 2.83433083 |
| 35 | Panhypogammaglobulinemia (HP:0003139) | 2.77431424 |
| 36 | 3-Methylglutaconic aciduria (HP:0003535) | 2.76557431 |
| 37 | Facial cleft (HP:0002006) | 2.76331637 |
| 38 | Thrombocytosis (HP:0001894) | 2.73903232 |
| 39 | Abnormality of the intervertebral disk (HP:0005108) | 2.73628319 |
| 40 | Progressive muscle weakness (HP:0003323) | 2.72675836 |
| 41 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.71345156 |
| 42 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.66721294 |
| 43 | Abnormality of cochlea (HP:0000375) | 2.66062358 |
| 44 | Periodontitis (HP:0000704) | 2.65564398 |
| 45 | Abnormality of homocysteine metabolism (HP:0010919) | 2.64498696 |
| 46 | Homocystinuria (HP:0002156) | 2.64498696 |
| 47 | Deep philtrum (HP:0002002) | 2.63077740 |
| 48 | Broad palm (HP:0001169) | 2.63061750 |
| 49 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.58737457 |
| 50 | Hyporeflexia of lower limbs (HP:0002600) | 2.57377633 |
| 51 | EMG: myopathic abnormalities (HP:0003458) | 2.55361257 |
| 52 | Acute lymphatic leukemia (HP:0006721) | 2.54933283 |
| 53 | Calcaneovalgus deformity (HP:0001848) | 2.53104749 |
| 54 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.50679298 |
| 55 | Late onset (HP:0003584) | 2.48466338 |
| 56 | Limb-girdle muscle atrophy (HP:0003797) | 2.46413548 |
| 57 | Autoimmune hemolytic anemia (HP:0001890) | 2.46341554 |
| 58 | Abnormal number of incisors (HP:0011064) | 2.45710704 |
| 59 | Mitochondrial inheritance (HP:0001427) | 2.40285751 |
| 60 | Round ear (HP:0100830) | 2.40005752 |
| 61 | Patellar aplasia (HP:0006443) | 2.38727788 |
| 62 | Hepatocellular necrosis (HP:0001404) | 2.37008134 |
| 63 | Ventricular tachycardia (HP:0004756) | 2.36955019 |
| 64 | Abnormality of T cell physiology (HP:0011840) | 2.35813765 |
| 65 | Deformed tarsal bones (HP:0008119) | 2.34235338 |
| 66 | Vertebral compression fractures (HP:0002953) | 2.31143174 |
| 67 | Spinal rigidity (HP:0003306) | 2.29983095 |
| 68 | Acute encephalopathy (HP:0006846) | 2.28366276 |
| 69 | Lipoatrophy (HP:0100578) | 2.26642016 |
| 70 | Increased hepatocellular lipid droplets (HP:0006565) | 2.26415362 |
| 71 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.26200845 |
| 72 | Polycythemia (HP:0001901) | 2.23337198 |
| 73 | Meckel diverticulum (HP:0002245) | 2.21947533 |
| 74 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.21591208 |
| 75 | Abnormality of the fingertips (HP:0001211) | 2.21339739 |
| 76 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.20538710 |
| 77 | Abnormality of the nasal mucosa (HP:0000433) | 2.19913234 |
| 78 | Myelodysplasia (HP:0002863) | 2.18570394 |
| 79 | Muscle stiffness (HP:0003552) | 2.18259319 |
| 80 | Premature rupture of membranes (HP:0001788) | 2.18002330 |
| 81 | Morphological abnormality of the inner ear (HP:0011390) | 2.17238926 |
| 82 | Abnormality of the calcaneus (HP:0008364) | 2.16356996 |
| 83 | Truncus arteriosus (HP:0001660) | 2.15941817 |
| 84 | Abnormal sex determination (HP:0012244) | 2.15714467 |
| 85 | Sex reversal (HP:0012245) | 2.15714467 |
| 86 | Seborrheic dermatitis (HP:0001051) | 2.15385847 |
| 87 | Muscle fiber atrophy (HP:0100295) | 2.15016119 |
| 88 | Difficulty running (HP:0009046) | 2.14820684 |
| 89 | Multiple enchondromatosis (HP:0005701) | 2.14272157 |
| 90 | Cerebral aneurysm (HP:0004944) | 2.13896544 |
| 91 | Myotonia (HP:0002486) | 2.13548725 |
| 92 | Increased variability in muscle fiber diameter (HP:0003557) | 2.12517585 |
| 93 | Subaortic stenosis (HP:0001682) | 2.10139338 |
| 94 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.10139338 |
| 95 | Hepatic necrosis (HP:0002605) | 2.09227511 |
| 96 | Progressive macrocephaly (HP:0004481) | 2.08713082 |
| 97 | Abnormality of the ileum (HP:0001549) | 2.08564683 |
| 98 | Calf muscle hypertrophy (HP:0008981) | 2.08014358 |
| 99 | Birth length less than 3rd percentile (HP:0003561) | 2.07663669 |
| 100 | Malignant hyperthermia (HP:0002047) | 2.06629789 |
| 101 | Beaking of vertebral bodies (HP:0004568) | 2.06204723 |
| 102 | Lipid accumulation in hepatocytes (HP:0006561) | 2.06173802 |
| 103 | Right ventricular cardiomyopathy (HP:0011663) | 2.05694931 |
| 104 | Increased CSF lactate (HP:0002490) | 2.02445861 |
| 105 | Aortic aneurysm (HP:0004942) | 2.01999839 |
| 106 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.01416890 |
| 107 | Ketoacidosis (HP:0001993) | 2.00784256 |
| 108 | Neck muscle weakness (HP:0000467) | 1.99423645 |
| 109 | B lymphocytopenia (HP:0010976) | 1.97726768 |
| 110 | Frequent falls (HP:0002359) | 1.97048403 |
| 111 | Increased serum lactate (HP:0002151) | 1.96094931 |
| 112 | Sudden death (HP:0001699) | 1.96030193 |
| 113 | Abnormality of the intrinsic pathway (HP:0010989) | 1.95766104 |
| 114 | Granulocytopenia (HP:0001913) | 1.95705721 |
| 115 | Rib fusion (HP:0000902) | 1.95589100 |
| 116 | Rhizomelia (HP:0008905) | 1.94562975 |
| 117 | Exercise intolerance (HP:0003546) | 1.93007364 |
| 118 | Nasal polyposis (HP:0100582) | 1.92938392 |
| 119 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.92545598 |
| 120 | Joint stiffness (HP:0001387) | 1.92422946 |
| 121 | Palpitations (HP:0001962) | 1.92299788 |
| 122 | Missing ribs (HP:0000921) | 1.92000169 |
| 123 | Respiratory difficulties (HP:0002880) | 1.91868060 |
| 124 | Dysostosis multiplex (HP:0000943) | 1.90278579 |
| 125 | Abnormality of the preputium (HP:0100587) | 1.90073336 |
| 126 | Abnormality of the labia minora (HP:0012880) | 1.89965755 |
| 127 | Type 2 muscle fiber atrophy (HP:0003554) | 1.88790426 |
| 128 | Abnormality of the calf musculature (HP:0001430) | 1.87233851 |
| 129 | Generalized aminoaciduria (HP:0002909) | 1.87028995 |
| 130 | Generalized amyotrophy (HP:0003700) | 1.86936566 |
| 131 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.86696338 |
| 132 | Severe combined immunodeficiency (HP:0004430) | 1.85642032 |
| 133 | Abnormality of chromosome stability (HP:0003220) | 1.85214349 |
| 134 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.84828366 |
| 135 | Dicarboxylic aciduria (HP:0003215) | 1.84828366 |
| 136 | Dilated cardiomyopathy (HP:0001644) | 1.84346544 |
| 137 | Peritonitis (HP:0002586) | 1.84192796 |
| 138 | Insulin resistance (HP:0000855) | 1.83724716 |
| 139 | Reticulocytosis (HP:0001923) | 1.83471592 |
| 140 | Increased serum ferritin (HP:0003281) | 1.82970536 |
| 141 | Colon cancer (HP:0003003) | 1.82968928 |
| 142 | Abnormality of glycolysis (HP:0004366) | 1.82815873 |
| 143 | Cerebral edema (HP:0002181) | 1.82460687 |
| 144 | Chronic bronchitis (HP:0004469) | 1.81348400 |
| 145 | Abnormality of B cell number (HP:0010975) | 1.80476860 |
| 146 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.79886639 |
| 147 | Mucopolysacchariduria (HP:0008155) | 1.79886639 |
| 148 | Increased intramyocellular lipid droplets (HP:0012240) | 1.79604562 |
| 149 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.79552638 |
| 150 | Abnormal platelet function (HP:0011869) | 1.79006780 |
| 151 | Impaired platelet aggregation (HP:0003540) | 1.79006780 |
| 152 | Overlapping toe (HP:0001845) | 1.78988241 |
| 153 | Impaired proprioception (HP:0010831) | 1.78886309 |
| 154 | Increased density of long bones (HP:0006392) | 1.78499860 |
| 155 | Hypoglycemic seizures (HP:0002173) | 1.78425065 |
| 156 | Cortical visual impairment (HP:0100704) | 1.77685221 |
| 157 | Testicular atrophy (HP:0000029) | 1.77454932 |
| 158 | Leukocytosis (HP:0001974) | 1.77200789 |
| 159 | Ketosis (HP:0001946) | 1.76954589 |
| 160 | Aplastic anemia (HP:0001915) | 1.76818742 |
| 161 | Cervical subluxation (HP:0003308) | 1.76573084 |
| 162 | Facial diplegia (HP:0001349) | 1.76307927 |
| 163 | Absent phalangeal crease (HP:0006109) | 1.76241646 |
| 164 | Cholecystitis (HP:0001082) | 1.76168928 |
| 165 | Abnormal gallbladder physiology (HP:0012438) | 1.76168928 |
| 166 | IgM deficiency (HP:0002850) | 1.76125658 |
| 167 | Recurrent abscess formation (HP:0002722) | 1.75641335 |
| 168 | Squamous cell carcinoma (HP:0002860) | 1.75041112 |
| 169 | Rhabdomyosarcoma (HP:0002859) | 1.73989122 |
| 170 | Abnormal cartilage morphology (HP:0002763) | 1.73196150 |
| 171 | Maternal diabetes (HP:0009800) | 1.73171054 |
| 172 | Degeneration of anterior horn cells (HP:0002398) | 1.73101899 |
| 173 | Abnormality of the anterior horn cell (HP:0006802) | 1.73101899 |
| 174 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.72956226 |
| 175 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.72739429 |
| 176 | Abnormality of DNA repair (HP:0003254) | 1.72651295 |
| 177 | Acute myeloid leukemia (HP:0004808) | 1.72369906 |
| 178 | Conjunctival hamartoma (HP:0100780) | 1.71233369 |
| 179 | Areflexia of lower limbs (HP:0002522) | 1.69328301 |
| 180 | Ragged-red muscle fibers (HP:0003200) | 1.68309127 |
| 181 | Type I transferrin isoform profile (HP:0003642) | 1.67924326 |
| 182 | Spondylolisthesis (HP:0003302) | 1.67128678 |
| 183 | Generalized muscle weakness (HP:0003324) | 1.67022164 |
| 184 | Duplicated collecting system (HP:0000081) | 1.66873967 |
| 185 | Abnormality of the common coagulation pathway (HP:0010990) | 1.66525770 |
| 186 | Gout (HP:0001997) | 1.65252075 |
| 187 | Thick lower lip vermilion (HP:0000179) | 1.64987904 |
| 188 | Large for gestational age (HP:0001520) | 1.64523957 |
| 189 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.64479949 |
| 190 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.64479949 |
| 191 | Cupped ribs (HP:0000887) | 1.64470682 |
| 192 | Easy fatigability (HP:0003388) | 1.64455747 |
| 193 | Deep venous thrombosis (HP:0002625) | 1.63431327 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.83920116 |
| 2 | ERN1 | 4.59137536 |
| 3 | PBK | 4.03697882 |
| 4 | FES | 3.99807007 |
| 5 | TTN | 3.60015257 |
| 6 | CDC7 | 3.53842434 |
| 7 | MAP3K13 | 3.28959559 |
| 8 | PKN2 | 3.00936992 |
| 9 | MAP2K3 | 2.80597796 |
| 10 | ICK | 2.80350645 |
| 11 | SRPK1 | 2.78730684 |
| 12 | BCKDK | 2.58634043 |
| 13 | VRK2 | 2.51175509 |
| 14 | EEF2K | 2.42773051 |
| 15 | NME2 | 2.30565827 |
| 16 | WEE1 | 2.11686676 |
| 17 | OBSCN | 2.05741793 |
| 18 | ZAP70 | 1.98508767 |
| 19 | MKNK1 | 1.90019253 |
| 20 | FLT3 | 1.87263324 |
| 21 | MAP3K3 | 1.80028564 |
| 22 | LRRK2 | 1.79252536 |
| 23 | KDR | 1.78775323 |
| 24 | MAPKAPK3 | 1.75887260 |
| 25 | TXK | 1.75388093 |
| 26 | TTK | 1.70298578 |
| 27 | MAP4K1 | 1.69184784 |
| 28 | SMG1 | 1.67918663 |
| 29 | ATR | 1.59504123 |
| 30 | MAP3K11 | 1.57458182 |
| 31 | TESK1 | 1.56873259 |
| 32 | PIK3CG | 1.54902718 |
| 33 | CDK12 | 1.54627435 |
| 34 | MKNK2 | 1.53726139 |
| 35 | NEK1 | 1.49131726 |
| 36 | RPS6KA4 | 1.49088352 |
| 37 | PIM2 | 1.45772406 |
| 38 | TGFBR1 | 1.40775699 |
| 39 | TYRO3 | 1.38209243 |
| 40 | BRSK2 | 1.36922397 |
| 41 | TGFBR2 | 1.35142149 |
| 42 | ALK | 1.32782277 |
| 43 | TBK1 | 1.32574080 |
| 44 | TAOK1 | 1.32389752 |
| 45 | PASK | 1.30141483 |
| 46 | MAP3K10 | 1.26993497 |
| 47 | NEK9 | 1.26225746 |
| 48 | EIF2AK1 | 1.23086758 |
| 49 | SCYL2 | 1.22978338 |
| 50 | CHEK1 | 1.19616744 |
| 51 | TIE1 | 1.17236433 |
| 52 | ILK | 1.15935708 |
| 53 | JAK3 | 1.15891286 |
| 54 | TESK2 | 1.15281536 |
| 55 | FGFR4 | 1.13343770 |
| 56 | STK10 | 1.09460114 |
| 57 | PLK4 | 1.08169196 |
| 58 | SIK1 | 1.07729702 |
| 59 | FER | 1.06258029 |
| 60 | TYK2 | 1.03745674 |
| 61 | PNCK | 1.02414072 |
| 62 | CHEK2 | 1.01565118 |
| 63 | TAOK3 | 0.96813292 |
| 64 | TAOK2 | 0.96680609 |
| 65 | TSSK6 | 0.96453709 |
| 66 | MYLK | 0.96394402 |
| 67 | PAK4 | 0.95335386 |
| 68 | STK4 | 0.94377522 |
| 69 | PTK6 | 0.93441535 |
| 70 | WNK1 | 0.92720269 |
| 71 | MAP3K8 | 0.91424603 |
| 72 | NME1 | 0.90591620 |
| 73 | ATM | 0.90192180 |
| 74 | PDGFRA | 0.87658035 |
| 75 | CLK1 | 0.85289377 |
| 76 | DMPK | 0.83004727 |
| 77 | TAF1 | 0.83000094 |
| 78 | BRD4 | 0.82767972 |
| 79 | LIMK1 | 0.82222876 |
| 80 | PLK3 | 0.81704242 |
| 81 | EPHA3 | 0.81535878 |
| 82 | BUB1 | 0.81094979 |
| 83 | MAP2K6 | 0.80978375 |
| 84 | IRAK3 | 0.80731481 |
| 85 | MOS | 0.79912275 |
| 86 | RPS6KB2 | 0.78812842 |
| 87 | PDK4 | 0.78089022 |
| 88 | PDK3 | 0.78089022 |
| 89 | STK16 | 0.78014306 |
| 90 | BLK | 0.77933061 |
| 91 | CSNK1E | 0.75662398 |
| 92 | EIF2AK2 | 0.75162307 |
| 93 | MAP3K5 | 0.74944886 |
| 94 | BTK | 0.74441385 |
| 95 | AURKB | 0.72530356 |
| 96 | PLK1 | 0.71691141 |
| 97 | MAP3K1 | 0.71345233 |
| 98 | CDK2 | 0.70964368 |
| 99 | EIF2AK3 | 0.70185010 |
| 100 | CDK7 | 0.68501895 |
| 101 | NUAK1 | 0.68362961 |
| 102 | FGFR2 | 0.67355548 |
| 103 | KIT | 0.65541425 |
| 104 | KSR2 | 0.63902923 |
| 105 | RIPK1 | 0.62214843 |
| 106 | BMPR1B | 0.61800663 |
| 107 | CDK1 | 0.61638977 |
| 108 | PAK2 | 0.61503029 |
| 109 | MAP3K7 | 0.61075856 |
| 110 | DYRK2 | 0.59839818 |
| 111 | JAK1 | 0.59389565 |
| 112 | MAPK11 | 0.57436574 |
| 113 | MAP2K1 | 0.57084531 |
| 114 | BRSK1 | 0.56240681 |
| 115 | BRAF | 0.55893217 |
| 116 | NLK | 0.55590635 |
| 117 | VRK1 | 0.55098065 |
| 118 | CSNK2A2 | 0.54823562 |
| 119 | SYK | 0.54488936 |
| 120 | PRKG2 | 0.52158655 |
| 121 | LATS2 | 0.50984010 |
| 122 | UHMK1 | 0.50040588 |
| 123 | FGFR1 | 0.49777340 |
| 124 | TEC | 0.49662617 |
| 125 | CDK19 | 0.49152954 |
| 126 | DAPK3 | 0.48818901 |
| 127 | PRKD3 | 0.47378556 |
| 128 | MAPK12 | 0.45607633 |
| 129 | DYRK3 | 0.44972200 |
| 130 | CDK3 | 0.44585408 |
| 131 | PTK2 | 0.44053494 |
| 132 | DAPK1 | 0.43841495 |
| 133 | PRKDC | 0.43572393 |
| 134 | PHKG2 | 0.42897103 |
| 135 | PHKG1 | 0.42897103 |
| 136 | CDK4 | 0.42552244 |
| 137 | ITK | 0.42034694 |
| 138 | RPS6KA1 | 0.41543149 |
| 139 | MAPKAPK2 | 0.41429905 |
| 140 | MARK3 | 0.39609441 |
| 141 | TRPM7 | 0.39293086 |
| 142 | KSR1 | 0.38519122 |
| 143 | MAPK14 | 0.38083975 |
| 144 | CSNK2A1 | 0.37741503 |
| 145 | RAF1 | 0.37549691 |
| 146 | LCK | 0.37535529 |
| 147 | MAP2K2 | 0.36958905 |
| 148 | MTOR | 0.36255358 |
| 149 | JAK2 | 0.35788118 |
| 150 | PRKCH | 0.35640953 |
| 151 | NEK2 | 0.35262478 |
| 152 | MAP3K14 | 0.34944166 |
| 153 | CSF1R | 0.34575919 |
| 154 | TNIK | 0.33984260 |
| 155 | RPS6KC1 | 0.33596534 |
| 156 | CDK8 | 0.32938654 |
| 157 | RET | 0.29827558 |
| 158 | CAMKK2 | 0.29502271 |
| 159 | MAPK4 | 0.28479823 |
| 160 | ABL2 | 0.28293299 |
| 161 | RPS6KA6 | 0.28099758 |
| 162 | FGFR3 | 0.27880379 |
| 163 | PDK2 | 0.27628542 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RNA polymerase_Homo sapiens_hsa03020 | 4.37302170 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.01731868 |
| 3 | Spliceosome_Homo sapiens_hsa03040 | 3.77442851 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.27851168 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.87046322 |
| 6 | Homologous recombination_Homo sapiens_hsa03440 | 2.66115577 |
| 7 | RNA transport_Homo sapiens_hsa03013 | 2.64707247 |
| 8 | Mismatch repair_Homo sapiens_hsa03430 | 2.52067021 |
| 9 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.40942324 |
| 10 | Sulfur relay system_Homo sapiens_hsa04122 | 2.25553895 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.23580678 |
| 12 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.23326525 |
| 13 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.07419143 |
| 14 | Carbon metabolism_Homo sapiens_hsa01200 | 2.03721508 |
| 15 | Protein export_Homo sapiens_hsa03060 | 2.02507128 |
| 16 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.00945944 |
| 17 | RNA degradation_Homo sapiens_hsa03018 | 1.98834017 |
| 18 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.98816080 |
| 19 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.97830596 |
| 20 | Cell cycle_Homo sapiens_hsa04110 | 1.68413922 |
| 21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.67352567 |
| 22 | Parkinsons disease_Homo sapiens_hsa05012 | 1.66876980 |
| 23 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.65785708 |
| 24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.64154407 |
| 25 | Galactose metabolism_Homo sapiens_hsa00052 | 1.63032248 |
| 26 | Ribosome_Homo sapiens_hsa03010 | 1.60392839 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.59569972 |
| 28 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.59535493 |
| 29 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.59354219 |
| 30 | Purine metabolism_Homo sapiens_hsa00230 | 1.57286214 |
| 31 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.56880462 |
| 32 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.56380729 |
| 33 | Proteasome_Homo sapiens_hsa03050 | 1.54169235 |
| 34 | Other glycan degradation_Homo sapiens_hsa00511 | 1.51632256 |
| 35 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.44912213 |
| 36 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.40666554 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.40594941 |
| 38 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.39322011 |
| 39 | Huntingtons disease_Homo sapiens_hsa05016 | 1.33975052 |
| 40 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.33472372 |
| 41 | Basal transcription factors_Homo sapiens_hsa03022 | 1.32663435 |
| 42 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.32509493 |
| 43 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.31641399 |
| 44 | Leishmaniasis_Homo sapiens_hsa05140 | 1.27387648 |
| 45 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.26729785 |
| 46 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.26064526 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.25633996 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.25117642 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.21533017 |
| 50 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.21348967 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.19152239 |
| 52 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.17468975 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.17460620 |
| 54 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.13950727 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.11759254 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 1.05879084 |
| 57 | DNA replication_Homo sapiens_hsa03030 | 1.03786292 |
| 58 | Insulin resistance_Homo sapiens_hsa04931 | 1.03723040 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.02490477 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 1.02339405 |
| 61 | Bladder cancer_Homo sapiens_hsa05219 | 1.02056495 |
| 62 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.99163408 |
| 63 | Thyroid cancer_Homo sapiens_hsa05216 | 0.97864414 |
| 64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.97093285 |
| 65 | Lysosome_Homo sapiens_hsa04142 | 0.96487459 |
| 66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.93643987 |
| 67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.92111103 |
| 68 | Base excision repair_Homo sapiens_hsa03410 | 0.87139621 |
| 69 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.86880131 |
| 70 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.85822823 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.85527628 |
| 72 | Apoptosis_Homo sapiens_hsa04210 | 0.84540604 |
| 73 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84051777 |
| 74 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.81961371 |
| 75 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.81771840 |
| 76 | Alzheimers disease_Homo sapiens_hsa05010 | 0.78764319 |
| 77 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.78700189 |
| 78 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.78632101 |
| 79 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.78328114 |
| 80 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.76456563 |
| 81 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76158665 |
| 82 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.75846182 |
| 83 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.75234002 |
| 84 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.74556131 |
| 85 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.73037578 |
| 86 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.70760448 |
| 87 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.70503019 |
| 88 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70439902 |
| 89 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.69553031 |
| 90 | Focal adhesion_Homo sapiens_hsa04510 | 0.68688370 |
| 91 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.68656695 |
| 92 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.68611979 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.68494447 |
| 94 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.67976962 |
| 95 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.67528852 |
| 96 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.67416443 |
| 97 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.66379251 |
| 98 | Pertussis_Homo sapiens_hsa05133 | 0.66297188 |
| 99 | Platelet activation_Homo sapiens_hsa04611 | 0.65898702 |
| 100 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65668859 |
| 101 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64810551 |
| 102 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63095470 |
| 103 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.57355480 |
| 104 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.57221941 |
| 105 | Peroxisome_Homo sapiens_hsa04146 | 0.56883058 |
| 106 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.56408277 |
| 107 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56001822 |
| 108 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53813928 |
| 109 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.53345660 |
| 110 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.53113450 |
| 111 | Prostate cancer_Homo sapiens_hsa05215 | 0.53016985 |
| 112 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.52476202 |
| 113 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52443637 |
| 114 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.52040486 |
| 115 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.51437822 |
| 116 | Prion diseases_Homo sapiens_hsa05020 | 0.50321134 |
| 117 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.49996651 |
| 118 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.48856257 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.47996657 |
| 120 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47306410 |
| 121 | Amoebiasis_Homo sapiens_hsa05146 | 0.46701034 |
| 122 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46530066 |
| 123 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.45438270 |
| 124 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.45203488 |
| 125 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.44469772 |
| 126 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.44443544 |
| 127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43667239 |
| 128 | Hepatitis B_Homo sapiens_hsa05161 | 0.43413091 |
| 129 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43355378 |
| 130 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.42858133 |
| 131 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.42648896 |
| 132 | Measles_Homo sapiens_hsa05162 | 0.42091199 |
| 133 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41396280 |
| 134 | Influenza A_Homo sapiens_hsa05164 | 0.41273438 |
| 135 | * Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.40010546 |
| 136 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.37913532 |
| 137 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.37740773 |
| 138 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37644224 |
| 139 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.37328332 |
| 140 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33037588 |
| 141 | Metabolic pathways_Homo sapiens_hsa01100 | 0.31908441 |
| 142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31551395 |
| 143 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.30473140 |
| 144 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.29887337 |
| 145 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28353877 |
| 146 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.27423990 |
| 147 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.27020981 |
| 148 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.24583275 |
| 149 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.23964851 |
| 150 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23855352 |
| 151 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.22124015 |
| 152 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19605083 |
| 153 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.17379254 |
| 154 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.16736896 |
| 155 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.15812183 |
| 156 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.15455110 |
| 157 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.13336321 |

